Stock Price
1.63
Daily Change
0.04 2.52%
Monthly
1.24%
Yearly
22.56%
Q2 Forecast
1.60

Autolus Therapeutics Ltd reported $39.95M in Selling and Administration Expenses for its fiscal quarter ending in March of 2026.





Selling And Administration Expenses Change Date
AstraZeneca USD 5.06B 455M Mar/2026
Autolus Therapeutics Ltd USD 39.95M 4.16M Mar/2026
Hikma Pharmaceutical USD 288M 149M Dec/2025
Novartis USD 3.14B 296M Mar/2026
Roche Holding CHF 7.28B 3.99B Dec/2025
Silence Therapeutics USD 3.73M 2.06M Dec/2025